/
How to Overcome Barriers and Develop Collaborative Guidelin How to Overcome Barriers and Develop Collaborative Guidelin

How to Overcome Barriers and Develop Collaborative Guidelin - PowerPoint Presentation

phoebe-click
phoebe-click . @phoebe-click
Follow
400 views
Uploaded On 2016-06-29

How to Overcome Barriers and Develop Collaborative Guidelin - PPT Presentation

Amir Qaseem MD PhD MHA FACP Chair Guidelines International Network Director Clinical Policy American College of Physicians Conflicts of Interest Financial None Nonfinancial Guidelines International Network GIN ID: 382292

cancer american screening physicians american cancer physicians screening college collaboration prostate guideline association evidence recommends society amp decision process

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "How to Overcome Barriers and Develop Col..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

How to Overcome Barriers and Develop Collaborative Guidelines

Amir Qaseem, MD, PhD, MHA, FACPChair, Guidelines International Network Director, Clinical Policy, American College of PhysiciansSlide2

Conflicts of Interest

Financial: NoneNon-financial:Guidelines International Network (G-I-N)Institute of Medicine (IOM)Centers for Disease Control and Prevention (CDC)National Quality Forum (NQF)American Quality Alliance (AQA)

DECIDE projectSlide3

The Need for Collaboration(Prostate Cancer Screening)ACPM concludes that there is insufficient evidence to recommend routine population screening with digital rectal exam or prostate specific antigen.

ACS recommends that prostate cancer screening should not occur without an informed decision-making process. Men at average risk should receive this information beginning at age 50 years. Men in higher risk groups should receive this information before age 50 years.ACPM American College of Preventive Medicine

ACS American Cancer Society Slide4

The Need for Collaboration(Prostate Cancer Screening)AUA recommends that early detection and risk assessment of prostate cancer should be offered to asymptomatic men 40 years of age or older who wish to be screened and have an estimated life expectancy of more than 10 years.

USPSTF recommends against PSA-based screening for prostate cancer. AUA American Urological AssociationUSPSTF United States Preventive Services Task ForceSlide5

The Need for Collaboration(Prostate Cancer Screening)EAU recommends the decision to undergo early PSA testing should be a shared decision between the patient and his physician based on information balancing its advantages and disadvantages.

CCA recommends insufficient evidence for population based screening. EAU European Association of Urology CCA Cancer Council Australia and Andrology

Australia Slide6

Screening for Colorectal Cancer:

Qaseem et al: Ann Intern Med. 2012;156(5):378-386

2. I would recommend this guideline for

use.

(please

respond: yes, yes with modifications, or no

)

4 yes

2 yes with modifications

1 no

2 yes

3 yes with modifications

2 no

7 yes

7 noSlide7

The Need for CollaborationTarget AudienceClinicians (Advanced Practice Nurses, Allied Health Personnel, Nurses, Physicians)

PatientsHealth InsurersPolicy MakersSlide8

Process of Collaborative Guideline DevelopmentTopic selection & key questionsIdentification of relevant stakeholders

Establishing the ground rulesSlide9

Establish the Ground Rules for CollaborationFinancial SupportDissemination

Guideline Development GroupConflicts of InterestMemorandum of Understanding (MOU)TimelineSlide10

Establish the Ground Rules for CollaborationEvidence and outcomesKQ & clinical outcomes

What kind of evidence base will be used?How will recommendations be developed?What grading system will be used?What decision making process will be used?How will you deal with disagreement on evidence or recommendations?What processes need to be followed for each society to approve the guideline?Slide11

Benefits of CollaborationReduce the number of guidelines and potentially differing recommendations on the same topic (harmonization)Conserve resources

Incorporate more stakeholders in the development process, which results in a better and more widely accepted guidelineReach a larger, more diverse audienceSlide12

Barriers & HurdlesLonger time to complete the guidelineCompromise on methods/outcomesChallenge to arrive at consensus for difficult topicsSlide13

Many Successful Examples…Diagnosis & Management of Patients with Stable Ischemic Heart Disease (American College of Physicians/American College of Cardiology Foundation/American Heart Association/ American Association for Thoracic Surgery/ Preventive Cardiovascular Nurses Association)

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease (American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society) Current Pharmacologic Treatment of Dementia (American College of Physicians and American Academy of Family Physicians)Diagnosis and Treatment of Low Back Pain (American College of Physicians and American Pain Society *

Veterans Affairs/Department of Defense) Slide14